The pharmaceutical supply chain moves medicines from raw material suppliers and manufacturers through wholesalers and distributors to pharmacies, hospitals and patients. It differs from most supply chains because patient safety is at stake: products must be authentic, stored within their labelled conditions and traceable to the source.
The structure below is general. Specific rules vary by country and product type, so companies must follow the requirements of the regulator in each market they serve, such as Health Canada in Canada.
Typical stages
- Raw materials and active ingredients. Suppliers provide active pharmaceutical ingredients and excipients, often from several countries.
- Manufacturing. Ingredients are formulated, filled, packaged and tested under quality systems.
- Quality release. Batches are reviewed and approved before they can be sold.
- Distribution. Wholesalers and distributors store and deliver to pharmacies, hospitals and clinics.
- Dispensing. Pharmacists and healthcare providers supply the medicine to patients.
- Returns, recalls and disposal. Expired, damaged or recalled products are removed from circulation and handled safely.
Cold chain and storage control
Many medicines, including numerous vaccines and biological products, must be kept within defined temperature ranges. Regulated medicines need documented temperature control, from the manufacturer through transport, storage and delivery. In practice that means qualified refrigerated storage, insulated or active temperature-controlled packaging, calibrated data loggers or sensors, and procedures for what to do when a reading goes outside the range. In Canada, winter conditions also create a risk of freezing for products that must not be frozen, so packaging and routing are planned for cold weather as well as heat.
Compliance and traceability
Manufacturers, distributors and pharmacies work under quality standards often described as good manufacturing practice and good distribution practice. These require written procedures, trained staff, controlled facilities and records that show what happened to each batch. Traceability by batch or lot lets a company identify where affected products went if a defect or safety problem is found. Many markets also have rules aimed at preventing counterfeit or diverted medicines, so supply partners are typically vetted and licensed.
Common risks
| Risk | Why it matters | Typical control |
|---|---|---|
| Temperature excursion | Product may lose effectiveness or become unsafe | Qualified packaging, monitoring, deviation procedures |
| Supply shortage | Few manufacturers or a single ingredient source can limit supply | Supplier diversification, safety stock, early warning |
| Counterfeit or diverted products | Patient harm and loss of trust | Licensed partners, serialization or tracking, audits |
| Quality failure | Contamination or errors can trigger recalls | Supplier qualification, batch testing, change control |
| Expiry and waste | Short shelf life and strict dating | First-expiry-first-out, demand planning |
| Cyber and data risk | Systems hold patient and batch information | Access controls, vendor security reviews |
Good practices
- Qualify suppliers and logistics providers before use and review them regularly.
- Map ingredient sources beyond the first tier for essential medicines.
- Validate transport lanes and packaging for the seasons they will face.
- Keep batch and temperature records complete and retrievable.
- Test recall procedures so affected stock can be located quickly.
- Plan for shortages with clear rules on allocation and substitution agreed with clinical staff.
Where AI and analytics fit
Forecasting tools can help plan production and inventory, sensor analytics can predict temperature risk on a lane, and monitoring tools can flag supplier or shortage signals. In a regulated setting, any system affecting product quality or records generally needs validation and documented change control, and its outputs should be reviewable by qualified staff. Analytics support the process but do not replace quality oversight.
Common questions
Why are medicine shortages hard to fix?
Manufacturing is regulated, capacity is specialised and approvals for new sites or suppliers take time, so supply cannot be redirected quickly.
Is cold chain needed for all medicines?
No. Many are stored at controlled room temperature, but all regulated medicines still have defined storage conditions that must be respected.
Sources and further reading
- MIT Center for Transportation and Logistics (MIT CTL)
- Canadian Centre for Cyber Security (Canadian Centre for Cyber Security)
- Council of Supply Chain Management Professionals (CSCMP)